| PRECLINICAL | evidence | Copper peptide activated cascade catalysis for glucose regulation and hypoxia reversing in infected diabetic wound healing. | GHK-Cu | — | 2026-08-01 |
| PRECLINICAL | evidence | Copper peptide activated cascade catalysis for glucose regulation and hypoxia reversing in infected diabetic wound healing. | GHK | — | 2026-08-01 |
| PRECLINICAL | evidence | Redox-Responsive GHK-Conjugated Sponge Spicules for Sustained Dermal Delivery and Enhanced Collagen Synthesis. | GHK | — | 2026-06-21 |
| PRECLINICAL | evidence | Hierarchical regulation and mechanism of "open-hollow-fibrous network" structures: Osteogenic-angiogenic coupling responses of poly(gamma-benzyl-L-glutamate) microspheres. | GHK-Cu | — | 2026-06-15 |
| PRECLINICAL | evidence | Hierarchical regulation and mechanism of "open-hollow-fibrous network" structures: Osteogenic-angiogenic coupling responses of poly(gamma-benzyl-L-glutamate) microspheres. | GHK | — | 2026-06-15 |
| PRECLINICAL | evidence | Extracellular matrix-derived matrikines as emerging modulators of neuroinflammation and central nervous system signaling. | GHK | — | 2026-05-26 |
| PRECLINICAL | evidence | Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs. | GHK | — | 2026-05-26 |
| PRECLINICAL | evidence | Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs. | GHK-Cu | — | 2026-05-26 |
| PRECLINICAL | evidence | Glycyl-l-histidyl-l-lysine as a novel co-former in co-amorphous systems: Enhanced aqueous solubility and physical stability. | GHK | — | 2026-05-01 |
| PRECLINICAL | evidence | Copper(II)-Tripeptide Complexes as Potential Skin Healing Agents: Synthesis, Characterization, and Wound Repair Ability. | Copper tripeptide | — | 2026-04-28 |
| PRECLINICAL | evidence | Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives. | GHK | — | 2026-04-27 |
| PRECLINICAL | evidence | Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives. | GHK-Cu | — | 2026-04-27 |
| PRECLINICAL | evidence | Peptide-enriched hydrogel formulation for sensitive and damaged skin: from design to application testing. | GHK | — | 2026-04-24 |
| PRECLINICAL | evidence | Multi-Target Restoration of Dermal Elastic Fibers Through Elastin Upregulation, Elastase Suppression, and Scaffold Reinforcement. | Copper tripeptide-1 | — | 2026-04-22 |
| PRECLINICAL | evidence | Carbonless amino acids and a carbonless GHK peptide. | GHK | — | 2026-04-16 |
| PRECLINICAL | evidence | Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. | GHK | — | 2026-04-12 |
| PRECLINICAL | evidence | The Laccase-like Property of GHK-Cu and Its Applications in Colorimetric Sensing of Phenolic Compounds. | GHK | — | 2026-04-12 |
| PRECLINICAL | evidence | The Laccase-like Property of GHK-Cu and Its Applications in Colorimetric Sensing of Phenolic Compounds. | GHK-Cu | — | 2026-04-12 |
| PRECLINICAL | evidence | Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. | glycyl-L-histidyl-L-lysine copper | — | 2026-04-12 |
| PRECLINICAL | evidence | Extracellular Matrix-Derived Matrikines: Circulating Peptides as Candidate Mediators of Lung-to-Brain Signaling. | GHK | — | 2026-04-07 |
| PRECLINICAL | evidence | Golgi-targeted copper delivery strategy via enhancing copper-dependent proteins' activity for fascia regeneration. | GHK | — | 2026-02-10 |
| PRECLINICAL | evidence | Golgi-targeted copper delivery strategy via enhancing copper-dependent proteins' activity for fascia regeneration. | GHK-Cu | — | 2026-02-10 |
| PRECLINICAL | evidence | Impact of sleep fragmentation and estradiol suppression on positive and negative affect: Results of an experimental model of menopause. | GHK | — | 2026-02-01 |
| PRECLINICAL | evidence | Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. | GHK | — | 2026-01-01 |
| PRECLINICAL | evidence | Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. | GHK | Wound healing | 2026-01-01 |
| PRECLINICAL | evidence | Smart Healing for Wound Repair: Emerging Multifunctional Strategies in Personalized Regenerative Medicine and Their Relevance to Orthopedics. | GHK | — | 2026-01-01 |
| PRECLINICAL | evidence | Therapeutic peptides in gerontology: mechanisms and applications for healthy aging. | GHK | — | 2026-01-01 |
| PRECLINICAL | evidence | Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. | GHK-Cu | — | 2026-01-01 |
| PRECLINICAL | evidence | Therapeutic peptides in gerontology: mechanisms and applications for healthy aging. | GHK-Cu | — | 2026-01-01 |
| PRECLINICAL | evidence | Smart Healing for Wound Repair: Emerging Multifunctional Strategies in Personalized Regenerative Medicine and Their Relevance to Orthopedics. | GHK-Cu | — | 2026-01-01 |
| PRECLINICAL | evidence | Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. | GHK-Cu | — | 2026-01-01 |
| PRECLINICAL | evidence | Protective Functions of beta-Alanyl-L-Histidine and Glycyl-L-Histidyl-L-Lysine Glycoconjugates and Copper in Concert. | GHK | — | 2025-12-17 |
| PRECLINICAL | evidence | Biodegradable and anti-swelling peptide-based supermolecule hydrogel for eliminating ROS and inhibiting inflammation in acute spinal cord injury repair. | GHK | — | 2025-10-01 |
| PRECLINICAL | evidence | Gene-environment interaction analysis in atopic eczema: evidence from large population datasets and modelling in vitro. | GHK | — | 2025-09-04 |
| PRECLINICAL | evidence | Interaction of half-sandwich Rh(III) ion and some of its complexes with endogenous imidazole derivatives. | GHK | — | 2025-09-01 |
| PRECLINICAL | evidence | Efficacy and Safety Assessment of ThriveCo Scar Fader Gel With Scarcede in the Treatment of Skin Scars. | Copper tripeptide-1 | — | 2025-08-01 |
| PRECLINICAL | evidence | Gene-Environment Interaction Affects Risk of Atopic Eczema: Population and In Vitro Studies. | GHK | — | 2025-08-01 |
| PRECLINICAL | evidence | Intrinsically photoluminescent hydrogels to measure peptides‑copper binding affinities. | GHK | — | 2025-07-01 |
| PRECLINICAL | evidence | Enzyme-Mimicking Active Site Clefts Demonstrated by Self-Assembled Peptide Nanoribbons with Polar Zippers. | GHK | — | 2025-06-11 |
| PRECLINICAL | evidence | Accelerated Resolution of Pacemaker Pocket Hematoma With Adjunctive Phototherapy: A Case Report. | GHK | — | 2025-06-01 |
| PRECLINICAL | evidence | Intramolecular Charge Transfer-Induced Fluorescent Probe for the Sensitive Detection of Copper Tripeptide. | Copper tripeptide | — | 2025-05-22 |
| PRECLINICAL | evidence | Copper Complexes with New Glycyl-l-histidyl-l-lysine-Hyaluronan Conjugates Show Antioxidant Properties and Osteogenic and Angiogenic Synergistic Effects. | GHK | — | 2025-04-16 |
| PRECLINICAL | evidence | Copper Complexes with New Glycyl-l-histidyl-l-lysine-Hyaluronan Conjugates Show Antioxidant Properties and Osteogenic and Angiogenic Synergistic Effects. | GHK-Cu | — | 2025-04-16 |
| PRECLINICAL | evidence | Self-Assembled Peptide-Gold Nanoparticle 1D Nanohybrids Functionalized with GHK Tripeptide for Enhanced Wound-Healing and Photothermal Therapy. | GHK | — | 2025-03-12 |
| PRECLINICAL | evidence | Probiotic-Derived P8 Protein: Promoting Proliferation and Migration in Stem Cells and Keratinocytes. | GHK | — | 2025-02-28 |
| PRECLINICAL | evidence | Nanoengineered Self-Assembling Peptides with Increased Proteolytic Stability Promote Wound Healing. | GHK | — | 2025-02-26 |
| PRECLINICAL | evidence | Development and qualification of an LC-MS/MS method for quantification of MUC5AC and MUC5B mucins in spontaneous sputum. | GHK | — | 2025-02-01 |
| PRECLINICAL | evidence | Food-Derived Tripeptide-Copper Self-Healing Hydrogel for Infected Wound Healing. | Cu-GHK | — | 2025-01-01 |
| PRECLINICAL | evidence | Palmitoyl copper peptide and acetyl tyrosine complex enhances melanin production in both A375 and B16 cell lines. | GHK | Pigmentation | 2025-01-01 |
| PRECLINICAL | evidence | Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes? | GHK | Skin appearance & aging | 2025-01-01 |